The specificity of asciminib, a potential treatment for chronic myeloid leukemia, as a myristate-pocket binding ABL inhibitor and analysis of its interactions with mutant forms of BCR-ABL1 kinase - ScienceDirect
A schematic model of B-cell antigen receptor (BCR) engagement in... | Download Scientific Diagram
Hematology Reports | Free Full-Text | Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review | HTML
BCR (22q11) - ISH Probes - Molecular Pathology
BCR/TCR Structure, Antigen recognition, processing and presentation by MHC Flashcards | Quizlet
Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia - The Lancet
The amino acid residues of BCR-ABL kinase in the ponatinib binding... | Download Scientific Diagram
Mechanism of action of Imatinib; Imatinib binds to the ATP binding site... | Download Scientific Diagram
Efficient disruption of bcr-abl gene by CRISPR RNA-guided FokI nucleases depresses the oncogenesis of chronic myeloid leukemia cells | Journal of Experimental & Clinical Cancer Research | Full Text